A federal district judge awarded a whistleblower and the government $19,366,705 plus interest for false claims act and unjust enrichment allegations against Renal Care Group, Renal Care Group Supply Company, (RCGSC) and Fresenius Medical Care Holdings, Inc. According to findings by U.S. District Judge William J. Haynes, Jr., the DME companies “recklessly disregarded federal law when billing the Medicare program for home dialysis supplies and equipment from 1999 to 2005.” The Court’s opinion can be read in its entirety below:
[scribd id=28871463 key=key-1k36fgattodjdf3p83p5 mode=list]
In addition to striking an important blow against DME fraud, the opinion is significant in that it is one of few opinions that demonstrates how a company’s knowledge of false claims may be proven through evidence of reckless disregard of the Medicare regulations. Testimony in the case tended to show that while the company may have “technically” met certain independence requirements, “from a practical standpoint” the company was violating the spirit and the purpose of the Medicare regulations by causing a “benefit financially to the dialysis company to direct patients into the supply company.”
FraudBlawg UPDATE: READ MORE ABOUT the RENAL CARE GROUP FRAUD HERE.
To report dialysis equipment fraud or other DME fraud or Medicare Fraud, contact Frohsin & Barger.
[…] against Renal Care Group, Renal Care Group Supply Company and Fresenius Medical Care Holdings, Inc. The Court’s Order which was previously reported by FraudBlawg discusses: “complaints and concerns of multiple Renal Care Group employees who complained […]